Matthew Zola 12/17/25 Matthew Zola 12/17/25 VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement Read More Matthew Zola 12/15/25 Matthew Zola 12/15/25 GenSci and RTW Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and Thyroid Eye Disease, With Global Ex-China Development Being Led by Yarrow Bioscience Read More
Matthew Zola 12/17/25 Matthew Zola 12/17/25 VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement Read More
Matthew Zola 12/15/25 Matthew Zola 12/15/25 GenSci and RTW Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and Thyroid Eye Disease, With Global Ex-China Development Being Led by Yarrow Bioscience Read More
